In a breakthrough that bridges the gap between historical botanical mysteries and modern pharmaceutical potential, a West Virginia University undergraduate has identified a long-sought-after fungus. Corinne Hazel, an environmental microbiology major and Goldwater Scholar from Delaware, Ohio, successfully isolated a species of fungus that produces ergot alkaloids—the same chemical compounds that inspired the creation of the semisynthetic drug LSD. This discovery, published in the journal Mycologia, resolves a decades-old scientific enigma and opens new doors for potential therapeutic applications in the treatment of depression, post-traumatic stress disorder (PTSD), and addiction.

The new species, which Hazel and her faculty mentor, Daniel Panaccione, have named Periglandula clandestina, was discovered within the seed coats of morning glory plants. The name itself serves as a nod to the elusive nature of the organism, which has successfully avoided detection by researchers for generations. For decades, the presence of ergot alkaloids in morning glories led scientists to suspect that a hidden fungal partner was responsible for the plants’ psychoactive properties, yet the source remained perpetually out of reach until Hazel’s recent work in the WVU Davis College of Agriculture and Natural Resources.

The discovery began in the lab of Dr. Daniel Panaccione, the Davis-Michael Professor of Plant and Soil Sciences. Hazel, working under Panaccione’s guidance, was initially investigating the complex mechanisms by which morning glories disperse protective chemicals—specifically ergot alkaloids—through their root systems. It was during this routine examination of laboratory plant specimens that Hazel noticed an anomaly.

“We had a ton of plants lying around and they had these tiny little seed coats,” Hazel recalled. “We noticed a little bit of fuzz in the seed coat. That was our fungus.”

This keen observation shifted the focus of her research. Recognizing the potential significance of the "fuzz," the team prepared a DNA sample to confirm the identity of the organism. With the support of a WVU Davis College Student Enhancement Grant, Hazel was able to fund the genome sequencing necessary to verify that the fungus was, in fact, a previously unidentified species. The resulting genetic sequence has now been officially deposited in a recognized gene bank, bearing Hazel’s name as the discoverer.

For Dr. Panaccione, the achievement represents a milestone rarely reached by undergraduate students. “Sequencing a genome is a significant thing,” Panaccione noted. “It’s amazing for a student.”

The implications of the discovery extend far beyond the classification of a new fungus. The morning glory plant exists in a symbiotic relationship with this fungus, which produces the same ergot alkaloids that caught the attention of Swiss chemist Albert Hofmann in the late 1930s. Hofmann, who famously synthesized LSD, hypothesized that a specific fungus associated with morning glories was the biological source of the chemicals that gave the plants their psychedelic properties. While Hofmann and his contemporaries were able to identify the chemicals themselves, they were never able to isolate the biological "factory" responsible for producing them. The work of Hazel and Panaccione finally provides the missing link in this historical research.

“Morning glories contain high concentrations of similar lysergic acid derivatives that give them their psychedelic activities,” Panaccione explained. “This inspired Hofmann and others to investigate morning glories for the presence of a hidden fungus related to the ergot fungus that might be the source of these chemicals. They found very similar chemicals, but they could never find the fungus itself.”

Ergot alkaloids are a fascinating, if complex, class of compounds. Produced exclusively by fungi, they are frequently found in nature on grains such as rye. While these compounds have historically been associated with toxicity in both humans and livestock—sometimes resulting in severe health consequences when consumed accidentally—they have also been harnessed for their potent medicinal properties. Modern clinicians have long utilized various derivatives of these alkaloids to manage a range of conditions, including chronic migraines, dementia, uterine hemorrhaging, and Parkinson’s disease.

The discovery of Periglandula clandestina is particularly noteworthy because the fungus is highly efficient at producing these alkaloids in large quantities. This characteristic is precisely what makes it a compelling candidate for future pharmaceutical research. By studying how this specific fungus produces these compounds, scientists hope to develop methods to leverage their therapeutic benefits while mitigating the risks associated with their toxic side effects.

“Many things are toxic,” Panaccione observed. “But if you administer them in the right dosage or modify them, they can be useful pharmaceuticals. By studying them, we may be able to figure out ways to bypass the side effects. These are big issues for medicine and agriculture.”

The naming of the fungus reflects the collaborative spirit and the academic rigor of the WVU laboratory. The team chose the term clandestina because the fungus had managed to elude detection for so long, hiding in plain sight within the seed coats of the plants. For Panaccione, the process of the discovery has been as rewarding as the scientific outcome itself.

“I think that’s the perfect name,” Panaccione said. “And I love that we did this project together. Corinne has a ton of talent. It’s about students recognizing the opportunities, seizing them and having the skill and the brain power to bring this work to fruition.”

For Hazel, the discovery is the culmination of diligent laboratory work and a bit of serendipity. The ability to contribute to the body of botanical and microbiological knowledge as an undergraduate has been a defining experience of her academic career.

“I’m lucky to have stumbled into this opportunity,” Hazel said. “People have been looking for this fungus for years, and one day, I look in the right place, and there it is. I’m very proud of the work that I’ve done at WVU.”

Looking ahead, the research is far from complete. Hazel is currently focused on the challenge of culturing the fungus. As a slow-growing organism, Periglandula clandestina presents unique hurdles for researchers attempting to grow it in a controlled environment. Successfully establishing a robust culture would be the next critical step in understanding the chemical pathways that produce the alkaloids, potentially paving the way for larger-scale analysis.

Furthermore, the team is interested in exploring the broader ecosystem of morning glories. It remains an open question whether other species of morning glory might also host related fungal symbiotes that have yet to be identified or described by science. As Hazel continues her work, she remains dedicated to exploring the potential of this discovery, hoping that her efforts will eventually contribute to the development of safer, more effective treatments for the complex neurological and psychiatric conditions that continue to challenge the medical community.

The identification of Periglandula clandestina serves as a testament to the importance of basic research and the unexpected discoveries that can arise from deep, persistent investigation. By connecting a small, overlooked fuzz in a seed coat to the grand history of psychedelic chemistry and modern pharmaceutical needs, Hazel and Panaccione have added an important new chapter to the study of plant-fungal symbiosis. As the scientific community begins to analyze the implications of this new species, the work conducted at the WVU Davis College of Agriculture and Natural Resources stands as a prime example of how student-led research can solve long-standing mysteries and potentially shape the future of medicine.